INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
ME
Moritz Robert Edward Jr.Director
NTRSNORTHERN TRUST CORP
Grant or award
A—
989 sh
Apr 21, 2026Apr 23, 2026
Page 913 of 1737
← PrevNext →
traded Apr 21, 2026
+2d
SEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
22.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
300.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
286.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
LB
Larson Robert BruceSVP & Chief Accounting Officer
ACIAlbertsons Companies, Inc.
Option exercise
M—
16.7K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
RE
Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc
ACIAlbertsons Companies, Inc.
Option exercise
M—
13.6K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
309.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
81.8K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
33.9K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
MS
Mccollam SharonPresident & CFO
ACIAlbertsons Companies, Inc.
Tax withholding
F—
15.4K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
DA
Dhanda AnujChief Tech &Transformation Off
ACIAlbertsons Companies, Inc.
Option exercise
M—
24.5K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
110.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
128.6K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
HJ
Henricsson Nina JosefinChief Human Resources Officer
PSNYPolestar Automotive Holding UK PLC
Option exercise
M—
176 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
EH
Engstrom Jonas HakanChief Operating Officer
PSNYPolestar Automotive Holding UK PLC
Option exercise
M—
440 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
397.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
355.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
MP
McCarthy Eileen PGeneral Counsel Corp Sec
JBLUJETBLUE AIRWAYS CORP
Grant or award
A—
91.6K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
DJ
Dable Habib JDirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
32.3K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
PL
Pei Melinda LitherlandDirector
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
407 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
DJ
Dable Habib JDirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
22.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
65.6K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
204.6K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
LS
Laughlin ScottDirector
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
DH
Dhruv Anuj HasitEVP and CFO
WFRDWeatherford International plc
Option exercise
M—
11.2K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
TA
Tamboli AjimChief Financial Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
41.2K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
HM
Harrison Dean MDirector
NTRSNORTHERN TRUST CORP
Grant or award
A—
989 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
PL
Pei Melinda LitherlandDirector
BIOBIO.BBIO-RAD LABORATORIES, INC.
Grant or award
A—
369 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
32.3K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
MS
Morris SusanDirector, Chief Executive Officer
ACIAlbertsons Companies, Inc.
Option exercise
M—
39.3K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
14.3K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
286.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
22.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
808.3K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
PM
Peterson MichaelEXECUTIVE VICE PRESIDENT
SEICSEI INVESTMENTS CO
Option exercise
M—
10.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
GW
Grossman WilliamDirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
22.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Option exercise
M—
6,692 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
63.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence